Boltwood Capital Management’s St Jude Medical STJ Stock Holding History

Boltwood Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,935	Closed	-$876K	–	114
2016 Q4	$876K	Sell	10,935 -3,425	-24%	-$272K	0.67%	50
2016 Q3	$1.15M	Buy	14,360 +95	+0.7%	+$7.67K	0.92%	40
2016 Q2	$1.11M	Sell	14,265 -560	-4%	-$39.9K	0.93%	40
2016 Q1	$815K	Buy	14,825 +1,200	+9%	+$65.4K	0.72%	47
2015 Q4	$842K	Buy	13,625 +175	+1%	+$11K	0.77%	43
2015 Q3	$849K	Buy	13,450 +50	+0.4%	+$3.57K	0.9%	39
2015 Q2	$979K	Buy	+13,400	New	+$968K	0.96%	37

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Boltwood Capital Management's STJ Position: Q1 2017 in Review

Boltwood Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,935 shares — an estimated $876K sold.

Boltwood Capital Management first reported a position in STJ in Q2 2015 and held it in 7 quarters. The position peaked at $1.15M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Boltwood Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Boltwood Capital Management sold 10,935 St Jude Medical shares in Q1 2017, an estimated $876K.
Boltwood Capital Management first reported a position in St Jude Medical in Q2 2015 and held it in 7 quarters.
Boltwood Capital Management's St Jude Medical position peaked at $1.15M in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Boltwood Capital Management's 13F filing for Q1 2017, filed 6 Apr 2017.